PRAX - CIK 0001689548
Praxis Precision Medicines, Inc. (PRAX) reported net income of -$303.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$303.00M | -65.6% |
| FY 2024 | -$183.00M | -48.8% |
| FY 2023 | -$123.00M | +42.5% |
| FY 2022 | -$214.00M | -28.1% |
| FY 2021 | -$167.00M | -170.1% |
| FY 2020 | -$61.82M | -74.1% |
| FY 2019 | -$35.51M | - |
Praxis Precision Medicines, Inc. (PRAX) reported net income of -$303.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Praxis Precision Medicines, Inc.'s net income declined from -$35.51M to -$303.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.